TG Therapeutics Inc (TGTX)

Days of inventory on hand (DOH)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Inventory turnover		1.75	2.09	2.00	1.88	3.36	3.51	3.16	2.85	—	—	—	29.82	—	—	—	16.77	—	—	—	—
DOH	days	209.13	174.33	182.77	194.48	108.50	104.08	115.38	128.09	—	—	—	12.24	—	—	—	21.77	—	—	—	—

December 31, 2024 calculation

DOH = 365 ÷ Inventory turnover
= 365 ÷ 1.75
= 209.13

The days of inventory on hand (DOH) for TG Therapeutics Inc have shown fluctuations over the analyzed period. The DOH was not available for several quarters in 2020 and 2021. Starting March 31, 2022, there was a significant decrease in DOH to 12.24 days, indicating better inventory management or possibly a decrease in inventory levels.

However, this trend reversed dramatically by March 31, 2023, with DOH spiking to 128.09 days, a substantial increase in inventory relative to sales. The following quarters continued to show elevated DOH levels, with June 30, 2023, and September 30, 2023, recording 115.38 days and 104.08 days, respectively.

The year 2024 started with a substantial increase in DOH, hitting 194.48 days by March 31, 2024, which indicates potential issues such as overstocking or slower inventory turnover. This trend persisted through the following quarters, with June 30, 2024, September 30, 2024, and December 31, 2024, showing 182.77 days, 174.33 days, and 209.13 days, respectively.

Overall, the DOH trend for TG Therapeutics Inc suggests fluctuations in inventory management efficiency, potentially impacted by changing sales patterns, procurement strategies, or production issues. Monitoring and addressing these fluctuations in DOH is crucial for optimizing working capital management and operational efficiency.